Items Tagged ‘heart disease’
October 29, 2020
Long-term safety, benefits of stem therapy for heart failure
The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]
Tags: cardiac regeneration, cardiopoietic stem cells, CHART-1 Trial, Dr. Andre Terzic, heart disease, Mayo Clinic Center for Regeneration, stem cell therapy
February 14, 2020
Evolution of cardiac regeneration
By Jen Schutz 
February is American Heart Month, a time to acknowledge advancements in a new generation of care. This year focus is placed on repairing damaged heart tissue and restoring heart function after a heart attack. The Mayo Clinic Center for Regenerative Medicine is leading research into cardiac regeneration. Accounting for nearly 20 million of all deaths, […]
Tags: #American Heart Month, #Dr. Michael Sabbah, cardiac regeneration, Dr. Atta Behfar, heart attack, heart disease, Mayo Clinic Center for Regenerative Medicine
December 19, 2019
Off the Shelf Vessels: A Regenerative Approach for Coronary Artery Bypass
By Jen Schutz
Growing blood vessels in a lab for human use may sound like a futuristic dream. However, Mayo Clinic researchers are seeking to do just that to advance a regenerative approach to coronary bypass graft surgery. Through a Regenerative Medicine Minnesota grant, a Mayo research team is developing tissue that could grow into a blood vessel […]
Tags: blood vessels, bypass, coronary artery disease, Dr. Leigh Griffiths, heart disease, vascular tissue engineering
July 26, 2019
Research for Infants with HLHS Moves Forward
By Jen Schutz
Hypoplastic left heart syndrome (HLHS) is a complex and rare heart defect present at birth in which the left side of a child’s heart is severely underdeveloped. At Mayo Clinic, physicians and researchers in the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome are looking for ways to delay or even prevent heart failure […]
Tags: clinical trial, Dr. Timothy Nelson, heart disease, HLHS, hypoplastic left heart syndrome, Medical Research, phase I trial, regenerative medicine, stem cells, Todd and Karen Wanek Family Program for HLHS
November 19, 2014
Mayo Scientist Receives American Heart Association 2014 Basic Research Prize
The American Heart Association (AHA) awarded the 2014 Basic Research Prize to Andre Terzic, M.D., Ph.D., of Mayo Clinic. The award, presented at the annual meeting of the American Heart Association in Chicago, recognizes outstanding contributions to the advancement of cardiovascular science. Dr. Terzic was commended for pioneering applications of emerging technologies to advance the diagnosis […]
Tags: American Heart Association, Andre Terzic, cardiology, heart disease, Mayo Clinic, Minnesota news release, regenerative medicine, stem cells
January 21, 2014
Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients
Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy. The trial will test the Mayo Clinic discovery of cardiopoietic (cardiogenically-instructed) stem cells designed to improve heart health in people suffering from heart failure. The multisite U.S. trial, called CHART-2, will aim to recruit […]
Tags: Andre Terzic, Atta Behfar, cardiac regeneration, Cardio3 Biosciences, European stem cell trial, heart disease, Mayo Clinic, regenerative medicine, stem cells